310.25
-2.68%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Shivalik Rasayan
Its shares trade on NSE under the ticker SHIVALIK.NS. It has been listed since 22 May 2015. In the fiscal year to 31 March 2026, it reported revenue of ₹3.68bn and net income of ₹121.4m. At that date it held total assets of ₹8.19bn and shareholders' equity of ₹5.99bn.
Shivalik Rasayan Ltd. engages in the manufacture of pharmaceutical and agrochemical products. The company is headquartered in New Delhi, Delhi. The company went IPO on 2015-05-22. The firm is the producer of Dimethoate Technical and the Malathion Technical in India. The company also manufactures organophosphorus-based insecticides and chemicals. Its business units include API, Formulation, Research and Development, Agrochemical, Specialty Chemicals and Intellectual Property. The company offers solutions from product selection to development till commercialization for a range of oncology and non-oncology products. Its oncology products include Azacitidine, Busulfan, Bortezomib, and various others. Its non-oncology products include Fingolimod, Pirfenidone, Ambroxol HCL, and others. Its Dimethoate Technical is used in preparation of formulations used in the control of a range of insect and mites. Its Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide used for a variety of food/feed crops.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 22 May 2015
- Employees
- 256
- Website
- shivalikrasayan.com ↗
Leadership
Pay as last reported
- Mr. Rahul BishnoiChairman of the Board, since 2002
- Mr. Suresh SinghWhole- Time Vice Chairman of the Board, since 1997₹2.3m
- Mr. Vinod KumarChief Financial Officer₹833,000
- Mr. Parul ChoudharyCompliance Officer, Company Secretary₹519,000
- Dr. Vimal ShrawatManaging Director, Non-Independent Executive Director, since 2018₹19.0m
- Mr. Sanjay BansalNon- Executive Non-independent Director
- Mr. Ashwani SharmaNon-Executive Non-Independent Director, since 2003₹5.7m
- Mr. Sham GoelIndependent Director
- Mr. Ramit MadanIndependent Director
- Mr. Shaival SaurabhIndependent Director
- Dr. Ravi BansalNon-Executive Independent Director
- Ms. Sangeeta BishnoiNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Shivalik Rasayan Ltd produces Dimethoate Technical and Malathion Technical in India.
- The company manufactures organophosphorus-based insecticides and chemicals for agricultural use.
- Shivalik Rasayan Ltd offers oncology and non-oncology products including Azacitidine and Fingolimod.
Weaknesses
- The company employs 256 full-time employees in New Delhi, India.
- Shivalik Rasayan Ltd has a limited business unit focus on API and Formulation.
- The firm's IPO listing date is 22 May 2015, which may affect investor interest.
Opportunities
- Shivalik Rasayan Ltd can expand its specialty chemicals business in the Indian market.
- The company has potential to grow in the oncology segment with products like Bortezomib.
- Shivalik Rasayan Ltd can leverage its R&D capabilities for new product development.
Threats
- The company faces competition from other chemical manufacturers in the Indian market.
- Shivalik Rasayan Ltd's reliance on organophosphorus-based insecticides may pose environmental concerns.
- The firm's business is subject to regulatory changes in the pharmaceutical and agrochemical sectors.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.